Ascletis Pharma (HKSE:01672) Change In Inventory : HK$0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Ascletis Pharma Change In Inventory?

Ascletis Pharma's change in inventory for the quarter that ended in Dec. 2024 was HK$0.00 Mil. It means Ascletis Pharma's inventory stayed the same from Jun. 2024 to Dec. 2024 .

Ascletis Pharma's change in inventory for the fiscal year that ended in Dec. 2024 was HK$-3.84 Mil. It means Ascletis Pharma's inventory increased by HK$3.84 Mil from Dec. 2023 to Dec. 2024 .

Ascletis Pharma's Total Inventories for the quarter that ended in Dec. 2024 was HK$4.67 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Ascletis Pharma's Days Inventory for the quarter that ended in Dec. 2024 was 1,817.04.

Inventory Turnover measures how fast the company turns over its inventory within a year. Ascletis Pharma's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.10.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Ascletis Pharma's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 4.25.

Ascletis Pharma Change In Inventory Historical Data

The historical data trend for Ascletis Pharma's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascletis Pharma Change In Inventory Chart

Ascletis Pharma Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

-21.78

-6.21

-14.34

-8.81

-3.84

Ascletis Pharma Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Inventory	Get a 7-Day Free Trial												-8.06	-	-	-	-

Ascletis Pharma Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.00 Mil.

Ascletis Pharma (HKSE:01672) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Ascletis Pharma's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	5.8245	/	0.585	*	365 / 2
	=	1,817.04

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Ascletis Pharma's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.585	/	5.8245
	=	0.10

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Ascletis Pharma's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	5.8245	/	1.37
	=	4.25

Ascletis Pharma Change In Inventory Related Terms

Thank you for viewing the detailed overview of Ascletis Pharma's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascletis Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascletis Pharma Inc (HKSE:01672) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

ASCLF:USA 2VJ:Germany

Address

198 Qidi Road, 12th Floor, Building D, HIPARK, Xiaoshan District, Zhejiang Province, Hangzhou, CHN, 311200

Website

https://www.ascletis.com

Ascletis Pharma Inc is an investment holding company. Along with its subsidiaries, it is engaged in the research and development, production, marketing, and sale of pharmaceutical products. It has three marketed products, i.e. Ritonavir tablets, GANOVO, and ASCLEVIR. It also has other drug candidates in its pipeline in their different stages of development such as ASC22, ASC10, ASC11, and ASC40 among others. Geographically, it operates in Mainland China and other regions.

Executives

Wu Jinzi Jason	2101 Beneficial owner
Wu Judy Hejingdao	2101 Beneficial owner
Jjw12 Limited
Lakemont Holding Llc
Jjw11 Limited
C-bridge Capital Gp, Ltd.	2201 Interest of corporation controlled by you
Fu Wei	2201 Interest of corporation controlled by you
Tf Capital Ii Ltd.	2201 Interest of corporation controlled by you
Tf Capital, Ltd.	2201 Interest of corporation controlled by you
Kang Hua Investment Company Limited	2201 Interest of corporation controlled by you
Yang Dan	2201 Interest of corporation controlled by you

Ascletis Pharma Headlines

No Headlines